Baseline Eye Exams Urged

Baseline Eye Exams Urged

CHATTANOOGA, Tenn. (WDEF) – GLP-1 medications, often prescribed for diabetes management and weight loss, are growing in popularity in the U.S., with roughly 12% of adults having used them at some point.  These drugs can provide meaningful improvements in blood sugar control and support weight loss goals. However, recent reports have highlighted rare but potentially serious eye complications among some users. Allegedly loss of vision has doubled …

The Ozempic Generation Hits a Wall: New BMJ Study Links GLP-1 Drugs to Serious Eye Complications

A large-scale study published this week in The BMJ has delivered what may be the most consequential safety signal yet for the blockbuster class of GLP-1 receptor agonist drugs — medications like semaglutide (sold as Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) that have become the fastest-growing pharmaceutical category in history. The finding: patients using these drugs face a meaningfully elevated risk of a condition called non-…